Which has stronger earnings and valuation, CACI or EXPO?

CACI International has higher revenue and earnings than Exponent. CACI International is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CACI International $9.57B 1.50 $535.81M $24.15 26.82 Exponent $582.01M 5.59 $106.01M $2.23 30.06

Does the media refer more to CACI or EXPO?

In the previous week, CACI International had 17 more articles in the media than Exponent. MarketBeat recorded 24 mentions for CACI International and 7 mentions for Exponent. Exponent's average media sentiment score of 1.22 beat CACI International's score of 0.67 indicating that Exponent is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CACI International 6 Very Positive mention(s) 3 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Exponent 5 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, IT or EXPO?

Gartner has higher revenue and earnings than Exponent. Gartner is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Gartner $6.46B 1.99 $729.23M $11.15 17.27 Exponent $582.01M 5.59 $106.01M $2.23 30.06

Is IT or EXPO more profitable?

Exponent has a net margin of 17.67% compared to Gartner's net margin of 11.99%. Gartner's return on equity of 525.46% beat Exponent's return on equity. Company Net Margins Return on Equity Return on Assets Gartner 11.99% 525.46% 13.45% Exponent 17.67% 31.48% 15.53%

Does the media refer more to IT or EXPO?

In the previous week, Gartner had 38 more articles in the media than Exponent. MarketBeat recorded 45 mentions for Gartner and 7 mentions for Exponent. Exponent's average media sentiment score of 1.22 beat Gartner's score of 0.80 indicating that Exponent is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Gartner 19 Very Positive mention(s) 4 Positive mention(s) 15 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Exponent 5 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor EXPO or BAH?

In the previous week, Booz Allen Hamilton had 2 more articles in the media than Exponent. MarketBeat recorded 9 mentions for Booz Allen Hamilton and 7 mentions for Exponent. Booz Allen Hamilton's average media sentiment score of 1.23 beat Exponent's score of 1.22 indicating that Booz Allen Hamilton is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exponent 5 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Booz Allen Hamilton 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, PL or EXPO?

Exponent has higher revenue and earnings than Planet Labs PBC. Planet Labs PBC is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Planet Labs PBC $307.73M 27.37 -$246.86M -$1.14 N/A Exponent $582.01M 5.59 $106.01M $2.23 30.06

Is PL or EXPO more profitable?

Exponent has a net margin of 17.67% compared to Planet Labs PBC's net margin of -111.17%. Exponent's return on equity of 31.48% beat Planet Labs PBC's return on equity. Company Net Margins Return on Equity Return on Assets Planet Labs PBC -111.17% -105.29% -35.54% Exponent 17.67% 31.48% 15.53%

Does the media prefer PL or EXPO?

In the previous week, Planet Labs PBC had 1 more articles in the media than Exponent. MarketBeat recorded 8 mentions for Planet Labs PBC and 7 mentions for Exponent. Exponent's average media sentiment score of 1.22 beat Planet Labs PBC's score of 0.92 indicating that Exponent is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Planet Labs PBC 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Exponent 5 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, EXPO or AMTM?

Exponent has higher earnings, but lower revenue than Amentum. Exponent is trading at a lower price-to-earnings ratio than Amentum, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Exponent $582.01M 5.59 $106.01M $2.23 30.06 Amentum $14.20B 0.42 $66M $0.60 41.04

Is EXPO or AMTM more profitable?

Exponent has a net margin of 17.67% compared to Amentum's net margin of 1.04%. Exponent's return on equity of 31.48% beat Amentum's return on equity. Company Net Margins Return on Equity Return on Assets Exponent 17.67% 31.48% 15.53% Amentum 1.04% 11.74% 4.78%

Does the media refer more to EXPO or AMTM?

In the previous week, Exponent had 4 more articles in the media than Amentum. MarketBeat recorded 7 mentions for Exponent and 3 mentions for Amentum. Exponent's average media sentiment score of 1.22 beat Amentum's score of 0.82 indicating that Exponent is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exponent 5 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Amentum 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Exponent (EXPO) Competitors

$67.03 +0.24 (+0.36%)

As of 02:08 PM Eastern

Compare

EXPO vs. CACI, IT, BAH, PL, and AMTM

Should you buy Exponent stock or one of its competitors? MarketBeat compares Exponent with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Exponent include CACI International (CACI), Gartner (IT), Booz Allen Hamilton (BAH), Planet Labs PBC (PL), and Amentum (AMTM). These companies are all part of the "research & consulting services" industry.

How does Exponent compare to CACI International?

CACI International (NYSE:CACI) and Exponent (NASDAQ:EXPO) are both industrials companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

Exponent has a net margin of 17.67% compared to CACI International's net margin of 5.60%. Exponent's return on equity of 31.48% beat CACI International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CACI International	5.60%	15.65%	6.45%
Exponent	17.67%	31.48%	15.53%

In the previous week, CACI International had 17 more articles in the media than Exponent. MarketBeat recorded 24 mentions for CACI International and 7 mentions for Exponent. Exponent's average media sentiment score of 1.22 beat CACI International's score of 0.67 indicating that Exponent is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CACI International	6 Very Positive mention(s)	3 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Exponent	5 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

86.4% of CACI International shares are held by institutional investors. Comparatively, 92.4% of Exponent shares are held by institutional investors. 1.1% of CACI International shares are held by company insiders. Comparatively, 1.7% of Exponent shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

CACI International has higher revenue and earnings than Exponent. CACI International is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CACI International	$9.57B	1.50	$535.81M	$24.15	26.82
Exponent	$582.01M	5.59	$106.01M	$2.23	30.06

CACI International has a beta of 0.53, suggesting that its stock price is 47% less volatile than the broader market. Comparatively, Exponent has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market.

CACI International currently has a consensus price target of $685.82, indicating a potential upside of 5.90%. Exponent has a consensus price target of $81.00, indicating a potential upside of 20.84%. Given Exponent's higher probable upside, analysts clearly believe Exponent is more favorable than CACI International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CACI International	0 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.67
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Exponent beats CACI International on 10 of the 16 factors compared between the two stocks.

How does Exponent compare to Gartner?

Gartner (NYSE:IT) and Exponent (NASDAQ:EXPO) are both industrials companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

Gartner presently has a consensus target price of $185.50, indicating a potential downside of 3.66%. Exponent has a consensus target price of $81.00, indicating a potential upside of 20.84%. Given Exponent's stronger consensus rating and higher possible upside, analysts plainly believe Exponent is more favorable than Gartner.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gartner	2 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.17
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Gartner has higher revenue and earnings than Exponent. Gartner is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gartner	$6.46B	1.99	$729.23M	$11.15	17.27
Exponent	$582.01M	5.59	$106.01M	$2.23	30.06

91.5% of Gartner shares are held by institutional investors. Comparatively, 92.4% of Exponent shares are held by institutional investors. 2.6% of Gartner shares are held by company insiders. Comparatively, 1.7% of Exponent shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Exponent has a net margin of 17.67% compared to Gartner's net margin of 11.99%. Gartner's return on equity of 525.46% beat Exponent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Gartner	11.99%	525.46%	13.45%
Exponent	17.67%	31.48%	15.53%

Gartner has a beta of 0.94, suggesting that its stock price is 6% less volatile than the broader market. Comparatively, Exponent has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market.

In the previous week, Gartner had 38 more articles in the media than Exponent. MarketBeat recorded 45 mentions for Gartner and 7 mentions for Exponent. Exponent's average media sentiment score of 1.22 beat Gartner's score of 0.80 indicating that Exponent is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Gartner	19 Very Positive mention(s)	4 Positive mention(s)	15 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Exponent	5 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Gartner and Exponent tied by winning 8 of the 16 factors compared between the two stocks.

How does Exponent compare to Booz Allen Hamilton?

Exponent (NASDAQ:EXPO) and Booz Allen Hamilton (NYSE:BAH) are both mid-cap industrials companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

92.4% of Exponent shares are owned by institutional investors. Comparatively, 91.8% of Booz Allen Hamilton shares are owned by institutional investors. 1.7% of Exponent shares are owned by company insiders. Comparatively, 1.1% of Booz Allen Hamilton shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Exponent has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market. Comparatively, Booz Allen Hamilton has a beta of 0.34, meaning that its share price is 66% less volatile than the broader market.

Booz Allen Hamilton has higher revenue and earnings than Exponent. Booz Allen Hamilton is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exponent	$582.01M	5.59	$106.01M	$2.23	30.06
Booz Allen Hamilton	$11.22B	0.83	$851M	$6.36	12.19

Exponent pays an annual dividend of $1.24 per share and has a dividend yield of 1.8%. Booz Allen Hamilton pays an annual dividend of $2.36 per share and has a dividend yield of 3.0%. Exponent pays out 55.6% of its earnings in the form of a dividend. Booz Allen Hamilton pays out 37.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Exponent has increased its dividend for 12 consecutive years and Booz Allen Hamilton has increased its dividend for 14 consecutive years. Booz Allen Hamilton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Exponent has a net margin of 17.67% compared to Booz Allen Hamilton's net margin of 7.01%. Booz Allen Hamilton's return on equity of 76.71% beat Exponent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exponent	17.67%	31.48%	15.53%
Booz Allen Hamilton	7.01%	76.71%	11.48%

In the previous week, Booz Allen Hamilton had 2 more articles in the media than Exponent. MarketBeat recorded 9 mentions for Booz Allen Hamilton and 7 mentions for Exponent. Booz Allen Hamilton's average media sentiment score of 1.23 beat Exponent's score of 1.22 indicating that Booz Allen Hamilton is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exponent	5 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Booz Allen Hamilton	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Exponent presently has a consensus target price of $81.00, suggesting a potential upside of 20.84%. Booz Allen Hamilton has a consensus target price of $84.08, suggesting a potential upside of 8.46%. Given Exponent's stronger consensus rating and higher possible upside, equities analysts plainly believe Exponent is more favorable than Booz Allen Hamilton.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
Booz Allen Hamilton	4 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	1.93

Summary

Booz Allen Hamilton beats Exponent on 10 of the 19 factors compared between the two stocks.

How does Exponent compare to Planet Labs PBC?

Planet Labs PBC (NYSE:PL) and Exponent (NASDAQ:EXPO) are both mid-cap industrials companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

41.7% of Planet Labs PBC shares are held by institutional investors. Comparatively, 92.4% of Exponent shares are held by institutional investors. 16.4% of Planet Labs PBC shares are held by company insiders. Comparatively, 1.7% of Exponent shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Planet Labs PBC has a beta of 2.11, suggesting that its share price is 111% more volatile than the broader market. Comparatively, Exponent has a beta of 0.68, suggesting that its share price is 32% less volatile than the broader market.

Exponent has a net margin of 17.67% compared to Planet Labs PBC's net margin of -111.17%. Exponent's return on equity of 31.48% beat Planet Labs PBC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Planet Labs PBC	-111.17%	-105.29%	-35.54%
Exponent	17.67%	31.48%	15.53%

In the previous week, Planet Labs PBC had 1 more articles in the media than Exponent. MarketBeat recorded 8 mentions for Planet Labs PBC and 7 mentions for Exponent. Exponent's average media sentiment score of 1.22 beat Planet Labs PBC's score of 0.92 indicating that Exponent is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Planet Labs PBC	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Exponent	5 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Planet Labs PBC currently has a consensus target price of $35.36, suggesting a potential upside of 49.63%. Exponent has a consensus target price of $81.00, suggesting a potential upside of 20.84%. Given Planet Labs PBC's higher probable upside, analysts plainly believe Planet Labs PBC is more favorable than Exponent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Planet Labs PBC	2 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.33
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Exponent has higher revenue and earnings than Planet Labs PBC. Planet Labs PBC is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Planet Labs PBC	$307.73M	27.37	-$246.86M	-$1.14	N/A
Exponent	$582.01M	5.59	$106.01M	$2.23	30.06

Summary

Exponent beats Planet Labs PBC on 10 of the 16 factors compared between the two stocks.

How does Exponent compare to Amentum?

Exponent (NASDAQ:EXPO) and Amentum (NYSE:AMTM) are both mid-cap industrials companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings, valuation and media sentiment.

Exponent currently has a consensus target price of $81.00, indicating a potential upside of 20.84%. Amentum has a consensus target price of $32.00, indicating a potential upside of 29.95%. Given Amentum's higher probable upside, analysts clearly believe Amentum is more favorable than Exponent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
Amentum	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.47

Exponent has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market. Comparatively, Amentum has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market.

92.4% of Exponent shares are held by institutional investors. Comparatively, 39.9% of Amentum shares are held by institutional investors. 1.7% of Exponent shares are held by insiders. Comparatively, 19.4% of Amentum shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Exponent has a net margin of 17.67% compared to Amentum's net margin of 1.04%. Exponent's return on equity of 31.48% beat Amentum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exponent	17.67%	31.48%	15.53%
Amentum	1.04%	11.74%	4.78%

In the previous week, Exponent had 4 more articles in the media than Amentum. MarketBeat recorded 7 mentions for Exponent and 3 mentions for Amentum. Exponent's average media sentiment score of 1.22 beat Amentum's score of 0.82 indicating that Exponent is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exponent	5 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amentum	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Exponent has higher earnings, but lower revenue than Amentum. Exponent is trading at a lower price-to-earnings ratio than Amentum, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exponent	$582.01M	5.59	$106.01M	$2.23	30.06
Amentum	$14.20B	0.42	$66M	$0.60	41.04

Summary

Exponent beats Amentum on 11 of the 17 factors compared between the two stocks.

Get Exponent News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EXPO vs. The Competition

Export

Metric	Exponent	Professional Services Industry	Industrials Sector	NASDAQ Exchange
Market Cap	$3.25B	$7.90B	$10.85B	$12.92B
Dividend Yield	1.86%	3.77%	97.10%	10.20%
P/E Ratio	30.06	39.09	28.38	24.78
Price / Sales	5.59	25.95	347.37	107.95
Price / Cash	28.70	22.88	24.70	37.44
Price / Book	8.57	7.04	4.92	6.43
Net Income	$106.01M	$238.96M	$607.14M	$347.27M
7 Day Performance	-1.82%	2.28%	2.14%	2.53%
1 Month Performance	7.94%	7.94%	1.63%	-1.03%
1 Year Performance	-5.12%	-3.01%	14.59%	23.28%

Exponent Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EXPO Exponent	4.296 of 5 stars	$67.03 +0.4%	$81.00 +20.8%	-5.5%	$3.25B	$582.01M	30.06	1,212	Positive News
CACI CACI International	3.361 of 5 stars	$512.00 +2.9%	$609.09 +19.0%	+31.0%	$11.00B	$8.63B	21.12	25,000	Earnings Report Analyst Forecast
IT Gartner	3.8007 of 5 stars	$151.33 +0.2%	$173.10 +14.4%	-19.1%	$10.11B	$6.47B	14.95	20,244	Earnings Report
BAH Booz Allen Hamilton	3.8417 of 5 stars	$71.24 +2.2%	$84.08 +18.0%	-31.3%	$8.39B	$11.22B	11.20	31,500	Positive News
PL Planet Labs PBC	3.6717 of 5 stars	$21.57 +5.3%	$35.36 +64.0%	+274.4%	$7.30B	$307.73M	N/A	800

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EXPO) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exponent (EXPO) Competitors

EXPO vs. CACI, IT, BAH, PL, and AMTM

How does Exponent compare to CACI International?

Summary

How does Exponent compare to Gartner?

Summary

How does Exponent compare to Booz Allen Hamilton?

Summary

How does Exponent compare to Planet Labs PBC?

Summary

How does Exponent compare to Amentum?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EXPO vs. The Competition

Exponent Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Exponent (EXPO) Competitors

EXPO vs. CACI, IT, BAH, PL, and AMTM

How does Exponent compare to CACI International?

Is CACI or EXPO more profitable?

Does the media refer more to CACI or EXPO?

Do institutionals and insiders have more ownership in CACI or EXPO?

Which has stronger earnings and valuation, CACI or EXPO?

Which has more volatility and risk, CACI or EXPO?

Do analysts recommend CACI or EXPO?

Summary

How does Exponent compare to Gartner?

Do analysts recommend IT or EXPO?

Which has higher valuation and earnings, IT or EXPO?

Do institutionals & insiders have more ownership in IT or EXPO?

Is IT or EXPO more profitable?

Which has more volatility & risk, IT or EXPO?

Does the media refer more to IT or EXPO?

Summary

How does Exponent compare to Booz Allen Hamilton?

Do institutionals & insiders have more ownership in EXPO or BAH?

Which has more volatility and risk, EXPO or BAH?

Which has higher valuation & earnings, EXPO or BAH?

Is EXPO or BAH a better dividend stock?

Is EXPO or BAH more profitable?

Does the media favor EXPO or BAH?

Do analysts recommend EXPO or BAH?

Summary

How does Exponent compare to Planet Labs PBC?

Do insiders & institutionals believe in PL or EXPO?

Which has more volatility and risk, PL or EXPO?

Is PL or EXPO more profitable?

Does the media prefer PL or EXPO?

Do analysts rate PL or EXPO?

Which has higher valuation and earnings, PL or EXPO?

Summary

How does Exponent compare to Amentum?

Do analysts rate EXPO or AMTM?

Which has more risk and volatility, EXPO or AMTM?

Do institutionals & insiders have more ownership in EXPO or AMTM?

Is EXPO or AMTM more profitable?

Does the media refer more to EXPO or AMTM?

Which has higher earnings and valuation, EXPO or AMTM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EXPO vs. The Competition

Exponent Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools